Harel contributed to drug discovery technology developer Eikon Therapeutics' $518m series B round while a host of corporates are set to exit data management software provider Trifacta in a $400m acquisition.

Nexon has invested $400m in film and television studio Agbo while responsible credit card provider Petal raised $140m in an Encore Bank and Cuna Mutual-backed round.

Coinbase Ventures has returned to back the IRA-targeted alternatives investing scheme operator, as the unit diversifies its blockchain and crypto-themed portfolio.

Data software provider Weka raised $73m in a round led by Hitachi Ventures while Advance Publications exited social impact technology developer EverFi in a $750m acquisition.

Veon and Prosus helped B2B product marketplace ShopUp push its series B funding to $109m while Sunshine Insurance backed rounds for ImmuneOnco and Xuanzhu Biopharmaceutical.

In the second part of our look at the year's corporate venturing trends, we analyse fintech and enterprise bull markets along with some emerging regions.

Drug development platform creator Xbiome has raised nearly $100m in series B funding while bioindustrial startup services provider 21st.Bio secured a similar amount from Novo.

Corporate-backed unicorns Via and Cohesity have both confidentially filed to go public while autonomous driving technology developer Haomo.AI raised nearly $157m.

Mobile wallet developer Momo grabbed $200m in a Mizuho Bank-led round valuing it above $2bn while silicon wafer producer Mieke pulled in $188m.

China-based chipmakers Chipone Technology and Vastai Technologies raised a total of over $1.2bn while Reddit has confidentially filed to go public.